The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development

International Journal of Cancer. Journal International Du Cancer
Helen Dimaras, B L Gallie

Abstract

The transition from the benign retinal tumor retinoma to its malignant counterpart retinoblastoma is accompanied by the loss of expression of the p75(NTR) neurotrophin receptor. This change in expression is mimicked in the TAg-RB murine model of retinoblastoma, where early tumors retain expression of p75(NTR) and advanced tumors lack it. We sought to determine the functional effect on tumor development of absence of p75(NTR) from the onset of TAg-RB tumor initiation. TAg-RB mice were crossed with either p75(NTR) exon 3 (E3KO) or exon 4 knockout (E4KO) mice to produce TAg-RB offspring that lacked one or both normal p75(NTR) alleles. The average tumor area per eye as a percentage of retinal area was measured. TAg-RB/E3KO (TAg-RB(E3KO)) and heterozygous mice showed no significant difference in tumor area compared to the TAg-RB control mice at any time point studied. However, TAg-RB/E4KO (TAg-RB(E4KO)) and heterozygous mice displayed a significantly larger tumor area than the TAg-RB control mice. Furthermore, adenoviral-mediated expression of p75(NTR) in a p75(NTR)-deficient human retinoblastoma cell line resulted in increased apoptosis. Our results confirm that p75(NTR) suppresses progression of both human and TAg-RB murine retino...Continue Reading

References

Feb 15, 1990·Nature·J J WindleP L Mellon
Aug 1, 1974·Journal of the National Cancer Institute·T W ReidJ L Wilcox
Jun 17, 1998·Genes & Development·E Robanus-MaandagH te Riele
Jun 19, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J M Frade, Y A Barde
Jan 14, 1999·The Journal of Comparative Neurology·D A PetersonF H Gage
Aug 19, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·M Majdan, F D Miller
Dec 1, 2001·Science·R LeeB L Hempstead
Mar 9, 2002·Molecular and Cellular Biology·William C HahnRobert A Weinberg
Aug 10, 2002·Progress in Neurobiology·Philippe P Roux, Philip A Barker
Feb 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christine E PaulPhilip A Barker
Feb 27, 2004·Nature·Anders NykjaerClaus M Petersen
Jun 11, 2004·Cell Cycle·Jiakun ZhangMichael A Dyer
Jul 3, 2004·Genes & Development·David MacPhersonTyler Jacks
Sep 24, 2005·Genes, Chromosomes & Cancer·Marija OrlicBrenda L Gallie
May 16, 2006·Cellular and Molecular Life Sciences : CMLS·J C Arévalo, S H Wu
Nov 14, 2006·Genes, Chromosomes & Cancer·Ella BowlesBrenda L Gallie
Aug 19, 2007·PLoS Biology·Angela L M JohnstonDonna L Senger

❮ Previous
Next ❯

Citations

Apr 5, 2011·Nucleic Acids Research·Max KoeppelMarion Lohrum
Jun 6, 2009·Retina·Arupa GangulyCarol Shields
May 21, 2008·Cell Division·David Macpherson
Sep 17, 2010·Middle East African Journal of Ophthalmology·Mallikarjuna KandalamJyotirmay Biswas
Apr 18, 2009·Ophthalmic Genetics·Helen DimarasBrenda L Gallie
Nov 11, 2008·The Urologic Clinics of North America·Michael A S Jewett, Alvaro Zuniga
Jan 15, 2009·International Journal of Cancer. Journal International Du Cancer·Johannes H SchulteAngelika Eggert
Dec 8, 2010·Proteomics. Clinical Applications·Kandalam MallikarjunaSubramanian Krishnakumar
Oct 1, 2011·Ophthalmic Genetics·Nathalie Allaman-PilletDaniel F Schorderet
Jan 19, 2017·Oncotarget·Nathalie Allaman-PilletDaniel F Schorderet
Feb 6, 2020·Endocrine-related Cancer·Matthias BeyensKen Op de Beeck
Jun 9, 2016·International Journal of Cancer. Journal International Du Cancer·Michael O'HareTimothy W Corson
Apr 28, 2017·Molecular Medicine Reports·Dongdong TongFenghe Zhang
Aug 22, 2014·Molecular Cancer Research : MCR·Nathalie Allaman-PilletDaniel Francis Schorderet
Feb 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinsheng YuArie Perry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis